What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report Amgen's unaudited financial results for the fourth quarter and full year ended December 31, 2014, and its financial position as of December 31, 2014. It primarily serves to furnish the press release containing these results.

Where can I find the detailed financial results?

The detailed financial results are not directly presented in the 8-K form itself. Instead, they are provided in the press release dated January 27, 2015, which is attached as Exhibit 99.1 to this filing.

What are non-GAAP financial measures, and why does Amgen use them?

Non-GAAP financial measures are metrics that exclude or adjust for certain items from their most directly comparable GAAP measures. Amgen's press release explains that management believes these non-GAAP measures provide useful information to investors by offering a clearer view of the company's financial condition and operational results, and these measures are also used internally by management for operational decisions.

Is the information in this 8-K considered 'filed' for legal liability purposes?

No, the information furnished in Item 2.02 of this Current Report, including the press release, is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it subject to the liabilities of that section. It is also not incorporated by reference into other SEC filings unless explicitly stated.

AMGN 8-K: Earnings & Results

Summary

Amgen Inc. (AMGN) filed an 8-K on January 27, 2015, to report its unaudited financial results for the three months and full year ended December 31, 2014, as well as its financial position as of December 31, 2014. The filing primarily serves to furnish the press release detailing these results, which includes both U.S. GAAP and non-GAAP financial measures. Investors should note that this 8-K itself does not contain the detailed financial results but rather references the attached press release as the source of this information.

Key Highlights

1Amgen announced its unaudited financial results for the fourth quarter and full year 2014 on January 27, 2015.
2The filing includes the company's financial position as of December 31, 2014.
3The report incorporates a press release that provides detailed financial performance information.
4Both U.S. Generally Accepted Accounting Principles (GAAP) and non-GAAP financial measures are presented in the accompanying press release.
5Non-GAAP measures discussed include adjusted earnings per share, free cash flow, adjusted operating income, and others.
6Reconciliations between non-GAAP and comparable GAAP measures are provided within the press release.
7The information furnished is not considered 'filed' for certain sections of the Securities Exchange Act of 1934.

AMGEN INC 8-K Report, Financial Results (Jan 27, 2015)

Summary

Key Highlights

Frequently Asked Questions